She said it appears that the vaccines are still proving to be effective against the new Covid-19 variant, Omicron.
She explained that though the number of infections is rapidly increasing, the severity of the disease has not surged to a new level. Furthermore, she said that the evidence on Omicron is just emerging and it is premature to conclude.
Dr. Soumya added that all of the lab studies are pointing towards a reduction in neutralization capacity.
Also that it is clinically seen that people who have used vaccines, and people who had prior infections, are still getting breakthrough infections with the new variant.
Furthermore, she stressed that the new variant is infecting both vaccinated and unvaccinated people. As a result of this, she urged everyone to get the jab against Covid-19.
In similar news earlier reported by NEWSLEXPOINT.com, two studies from Britain on the new Omicron Covid-19 variant showed that Covid infections with the new variant are less likely to result in hospitalization compared to the Delta variant.
Experts cautiously welcomed the preliminary studies, one from Scotland another from England. Nonetheless, they stressed that the new strain’s heightened infectiousness could still negate an advantage in milder outcomes. They said this might still lead to more overall severe cases.
- OMICRON: Uganda Opts For Mandatory Border Testing
- British Data Indicates Low Hospitalization Rate for Omicron
- Uganda Among Only Five Countries To Keep Schools Shut In Pandemic
Please use the button below to contribute to Newslex Point, Inc. using a credit card or via PayPal.